Norges Bank Cyclerion Therapeutics, Inc. Transaction History

Norges Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$2.46 - $5.84 $30,663 - $72,795	-12,465 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$1.8 - $13.43 $22,437 - $167,404	12,465 New	12,465 $34,000
Q4 2019 Feb 12, 2020	SELL	$1.8 - $13.43 $22,437 - $167,404	-12,465 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$8.12 - $14.54 $101,215 - $181,241	12,465 New	12,465 $151,000
Q3 2019 Nov 08, 2019	SELL	$8.12 - $14.54 $101,215 - $181,241	-12,465 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$9.6 - $22.85 $119,664 - $284,825	12,465 New	12,465 $142,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.